crinecerfont
General
Pronunciation:
kri-ne-ser-font
Trade Name(s)
- Crenessity
Ther. Class.
none assigned
Pharm. Class.
temporary class
corticotropin-releasing factor type 1 receptor antagonistThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Crinecerfont." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580041/10/crinecerfont.
Vallerand AHA, Sanoski CAC. Crinecerfont. Davis's Drug Guide. F.A. Davis Company; 2026. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580041/10/crinecerfont. Accessed June 27, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Crinecerfont. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580041/10/crinecerfont
Vallerand AHA, Sanoski CAC. Crinecerfont [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 27]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580041/10/crinecerfont.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - crinecerfont
ID - 3580041
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580041/10/crinecerfont
PB - F.A. Davis Company
ET - 20
DB - Nursing Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

